Industry News
Share your love
Sifi and Avanzanite Sign License Agreement
Italy-based Sifi formed a collaboration with Avanzanite Bioscience, a Dutch specialty pharmaceutical business, to commercialize and distribute Akantior (polihexanide) exclusively in 26 European Economic Area and Swiss countries. Sifi will manage all ongoing regulatory activities under the terms of the…
Harrow Now Offering Fortisite Formulations for In-Office Use
Harrow announced the availability of Fortisite (compounded Tobramycin 1.5% + Vancomycin 5%) for in-office use from its FDA-registered and FDA-inspected ImprimisRx 503B outsourcing facility. Fortisite formulations are high-concentration, refrigeration-stable, fortified antibiotic formulations in solution that are patent-pending. According to Harrow,…
FDA Greenlights Genentech’s Vabysmo | OBN
The FDA has approved Genentech’s Vabysmo (faricimab-svoa) for the treatment of wet age-related macular degeneration (AMD) and diabetic macular edema (DME), marking the first bispecific antibody approved for the eye. Vabysmo is also the first and only FDA-approved injectable eye…
Amgen to Buy Horizon Therapeutics
Amgen announced it is acquiring rare disease drug company Horizon Therapeutics, maker of eye disease drugs Tepezza and Uplizna, in a deal valued at $27.8 billion. The company will pay $116.50 in cash per share, a premium of 19.7% to…
AAO Guidelines For Standardizing Images In Ophthalmology I OBN
Ophthalmic imaging device makers have been urged to standardize image formats in order to adhere to the Digital Imaging and Communications in Medicine (DICOM) standard, according to a recent report by the American Academy of Ophthalmology. By establishing a uniform…
Rayner’s RayOne EMV IOL Approved By FDA I OBN
Since producing the first IOL in the world in 1949, Rayner has led the way in innovation, focusing on giving you and your patients the best IOLs and opthalmic solutions while always being guided by research to enhance patient outcomes…
Turkey, Lets In The SIFI 6th Biggest Pharma. Company In Europe
The Granting of Marketing Authorizations in Turkey – The Turkish Medicines and Medical Devices Agency (TMMDA) has approved the transfer of marketing authorizations for “SIFI”, a leading ophthalmic company, headquartered in Italy, focusing on eye care since 1935. Leading ophthalmic products, including NETILDEX®, NETIRA® and EYESTIL® will…